Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Endocr Relat Cancer. 2019 Nov;26(11):R627–R652. doi: 10.1530/ERC-19-0165

Table 3.

Beta-emitting radionuclides for targeted radionuclide therapy

Radionuclide Half-life (d) Max energy of emitted particle (Mev) Path length (mm)
Max-Mean
Useful γ for post-therapy imaging
177Lu 6.7 0.5 2.2–0.3 Yes
90Y 2.7 2.3 11.9–2.5 No
131I 8 0.81 2.4–0.3 Yes

d: days; 131I: Iodine-131; 177Lu: Lutetium-177; Mev: mega electron volt; mm: millimeter; 90Y: Yttrium-90